OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 1 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $435,000 | -22.9% | 131,257 | -90.0% | 0.96% | -28.3% |
| Q2 2016 | $564,000 | -23.3% | 1,312,575 | 0.0% | 1.34% | -8.9% |
| Q1 2016 | $735,000 | -67.4% | 1,312,575 | 0.0% | 1.47% | -57.6% |
| Q4 2015 | $2,258,000 | -18.5% | 1,312,575 | 0.0% | 3.46% | +0.4% |
| Q3 2015 | $2,770,000 | -64.1% | 1,312,575 | -15.9% | 3.44% | -31.6% |
| Q2 2015 | $7,726,000 | -65.8% | 1,560,775 | -45.9% | 5.03% | -55.4% |
| Q1 2015 | $22,584,000 | +23.5% | 2,884,305 | -4.4% | 11.28% | +8.0% |
| Q4 2014 | $18,286,000 | – | 3,017,445 | – | 10.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |